Notably, DKK3 has consistently been recognized as a tumor suppressor across various cancer types.[16, 31, 32] Aberrant promoter methylation can frequently lead to the downregulation of DKK3, thereby exerting a tumor‐suppressive effect. The gene discussed is DKK3; the disease is neoplasm.